Skip to content
Subscriber Only

Takeda Faces First Trial Over Actos Diabetes Drug in L.A.

Takeda Pharmaceutical Co., Asia’s biggest drugmaker, is facing its first trial of lawsuits alleging that its Actos diabetes drug caused cancer in some patients.

Jack Cooper, a former cable splicer for Pacific Bell who took Actos for more than two years, contends officials of Takeda’s U.S. unit didn’t properly warn consumers that Actos could cause bladder cancer. Jury selection in Cooper’s case is slated to begin to today in state court in Los Angeles.